About | Free Trial

Last Update

2015-10-18T00:00:00.000Z

This profile was last updated on // .

Is this you? Claim your profile.

Wrong Alexander Lussow?

Dr. Alexander Lussow R. PhD

Employee

QLT Inc.

Direct Phone: (604) ***-****       

QLT Inc.

887 Great Northern Way

Vancouver, British Columbia V5T 4T5

Canada

Company Description

QLT Inc. (QLT), is a global biopharmaceutical company engaged in the business of discovering, developing and commercialization of therapies. QLT has two commercial products, Visudyne and Eligard. Visudyne utilizes photodynamic therapy (PDT), to treat the ... more

Find other employees at this company (184)

Background Information

Employment History

Director
SangStat Medical Corporation

CBO and Vice President Business Development
Gryphon Therapeutics , Inc.

Managing Director
Broad Reach: The fastest way to sale (Sole Proprietorship) Chief Business

Adjunct Professor of Pharmacology
University of North Carolina , USA

Vice President, Business Development
Gryphon Sciences Inc

Education

Bachelor of Science degree

McGill University

PhD
immunology
University of Geneva , Switzerland

Web References (68 Total References)


Leadership | QLT Inc.

www.qltinc.com, $reference.date [cached]

Alexander Lussow Leadership | QLT Inc.

...
Alexander Lussow, Senior Vice President, Business Development and Commercial Operations
Alexander Lussow joined QLT in July 2006 as Vice President, Business Development and became Senior Vice President, Business Development and Commercial Operations in May 2008.
Dr. Lussow is responsible for QLT's business development activities, including product licensing, acquisitions and strategic partnering opportunities, as well as QLT's product manufacturing and supply chain.
Before joining QLT, Dr. Lussow was Gryphon Therapeutics' Chief Business Officer and Vice President of Business Development where he was responsible for the licensing of the company's products, the formation of strategic alliances, corporate communications and fund raising. Before joining Gryphon, Dr. Lussow served as the head of business development at Sangstat Medical Corporation (now wholly- owned by Genzyme Corp.). He also has broad experience in biotechnology management consulting, advising on venture financing, strategic business planning and licensing transactions for several biotechnology companies.
Dr. Lussow received his Bachelor of Science degree at McGill University in Montreal and his PhD in immunology at the University of Geneva, Switzerland. He has been an adjunct professor of pharmacology at the University of North Carolina, USA and has worked extensively for the World Health Organization (WHO) in West Africa.


Leadership | QLT Inc.

www.qltinc.com, $reference.date [cached]

Alexander Lussow, SENIOR Vice President, Business Development and commercial operations


Leadership | QLT Inc.

qlt.gssiwebs.com, $reference.date [cached]

Alexander Lussow

...
Alexander Lussow, SENIOR Vice President, Business Development and commercial operations


Leadership | QLT Inc.

qlt.gssiwebs.com, $reference.date [cached]

Alexander Lussow

...
Robert Butchofsky | Suzanne Cadden | Linda Lupini | Alexander Lussow | Christopher Muller | Cameron Nelson


Leadership | QLT Inc.

qlt.gssiwebs.com, $reference.date [cached]

Alexander Lussow | Alexander Lussow | Alexander Lussow, SENIOR Vice President, Business Development and commercial operations

...
Alexander Lussow | Alexander Lussow | Alexander Lussow, SENIOR Vice President, Business Development and commercial operations
...
Alexander Lussow | Alexander Lussow | Alexander Lussow, SENIOR Vice President, Business Development and commercial operations
...
Alexander Lussow
...
Robert Butchofsky | Suzanne Cadden | Linda Lupini | Alexander Lussow | Christopher Muller | Cameron Nelson
...
Alexander Lussow, Senior Vice President, Business Development and Commercial Operations
Alexander Lussow joined QLT in July 2006 as Vice President, Business Development and became Senior Vice President, Business Development and Commercial Operations in May 2008.
Dr. Lussow is responsible for QLT's business development activities, including product licensing, acquisitions and strategic partnering opportunities, as well as QLT's product manufacturing and supply chain.
Before joining QLT, Dr. Lussow was Gryphon Therapeutics' Chief Business Officer and Vice President of Business Development where he was responsible for the licensing of the company's products, the formation of strategic alliances, corporate communications and fund raising. Before joining Gryphon, Dr. Lussow served as the head of business development at Sangstat Medical Corporation (now wholly- owned by Genzyme Corp.). He also has broad experience in biotechnology management consulting, advising on venture financing, strategic business planning and licensing transactions for several biotechnology companies.
Dr. Lussow received his Bachelor of Science degree at McGill University in Montreal and his PhD in immunology at the University of Geneva, Switzerland. He has been an adjunct professor of pharmacology at the University of North Carolina, USA and has worked extensively for the World Health Organization (WHO) in West Africa.

Similar Profiles

Other People with this Name (41)

Other people with the name Lussow

Bill Lussow
Bespoke Commercial Real Estate LLC

Bruce Lussow
Filtran LLC Corporation Inc

Ken Lussow
Harley-Davidson , Inc.

Bret Lussow
Harrington Hoists Inc

Christine Lussow
CB Richard Ellis Inc

Browse ZoomInfo's Business Contact Directory by City

Browse ZoomInfo's
Business People Directory

Browse ZoomInfo's
Advanced Company Directory